Basics Kezar Life Sciences, Inc. IPO Date: June 18, 2018 Sector: Healthcare Industry: Biotech Market Cap: $45.77M Activated in VL: True Average Daily Range Avg Daily Range: $0.24 | 3.21% Avg Daily Range (30 D): $0.05 | 0.80% Avg Daily Range (90 D): $0.07 | 1.57% Institutional Daily Volume Avg Daily Volume: .4M Avg Daily Volume (30 D): .05M Avg Daily Volume (90 D): .12M Trade Size Avg Trade Size (Sh.): 124 Avg Trade Size (Sh.) (30 D): 154 Avg Trade Size (Sh.) (90 D): 134 Institutional Trades Total Inst.Trades: 544 Avg Inst. Trade: $1.77M Avg Inst. Trade (30 D): $.69M Avg Inst. Trade (90 D): $.69M Avg Inst. Trade Volume: .02M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.61M Avg Closing Trade (30 D): $4.17M Avg Closing Trade (90 D): $4.17M Avg Closing Volume: 23.01K     News Oct 17, 2025 @ 6:38 PM Kezar Launches Strategic Review As FDA Roadblock D... Source: Vandana Singh Oct 5, 2023 @ 3:00 PM Benzinga's Top Ratings Upgrades, Downgrades For Oc... Source: Benzinga Insights Oct 4, 2023 @ 1:32 PM Kezar (KZR) Falls 10% on Strategic Update, Reduces... Source: Zacks Equity Research Sep 21, 2023 @ 11:51 AM Why Murphy Canyon Acquisition Shares Are Trading H... Source: Lisa Levin Sep 21, 2023 @ 10:48 AM The economy is about to slow down. That's the time... Source: MarketWatch Financials   TTM Q3 2025 Q2 2025 Basic EPS $-8.44 $-1.53 Diluted EPS $-8.44 $-1.53 Revenue $ M $ M $ Gross Profit $ $ $ Net Income / Loss $ -61.71M $ -11.23M $ -13.7M Operating Income / Loss $ -65.51M $ -11.72M $ Cost of Revenue $ $ $ Net Cash Flow $ 4.08M $ $ PE Ratio     Splits Oct 30, 2024:   1:10